Zhejiang University: Colorectal Neoplasms trials

The registry lists 22 Colorectal Neoplasms studies with Zhejiang University as lead sponsor. 11 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 8Phase 3 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable MetastasesRecruitingNCT07789210Phase 2
• Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable MetastasesRecruitingNCT07581912Phase 2
• Effectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized TrialNot yet recruitingNCT07307547Not applicable
• The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal CancerRecruitingNCT07257653Phase 2
• China Colorectal Cancer Screening Trial 2 (C-Cost2)Not yet recruitingNCT07090304Not applicable
• China Colorectal Cancer Screening Trial 1 (C-Cost1)RecruitingNCT07090291Not applicable
• CDH17 CAR-T Therapy in Advanced Malignant Solid TumorsRecruitingNCT06937567Early Phase 1
• Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)RecruitingNCT06220617
• CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRDNot yet recruitingNCT05699746Phase 3
• NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal CancerRecruitingNCT05213195Phase 1
• Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRCRecruitingNCT04653480Phase 2
• Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in ChinaCompletedNCT04287335
• Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC PatientsCompletedNCT04080843Phase 2
• ePRO for Adjuvant Therapy of Colorectal AdenocarcinomaStatus unknownNCT04069455Not applicable
• Chemotherapy w/wo WeiLeShu in Metastatic Colorectal CancerCompletedNCT04021589Phase 2
• Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic DiseasesActive, not recruitingNCT03708952
• Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRCCompletedNCT03564912Phase 1/2
• Study Comparing Circular Stapler-assisted Colostomy vs Hand-stitching Colostomy of Colorectal Cancer PatientsTerminatedNCT02652702Phase 2
• Study Comparing Pursestring Wound Closure vs Conventional Closure to Reverse Stoma of Colorectal Cancer PatientsNo longer availableNCT02564224
• Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver MetastasisTerminatedNCT02453490Phase 3
• Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal CarcinomatosisCompletedNCT02179489Not applicable
• Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRMSuspendedNCT02121405Phase 3